Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temocillin vs cefotaxime for febrile urinary tract infection
2015-003898-15Phase 4Completed
- Sponsor
- Folkhälsomyndigheten
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in urinary tract infection (UTI) and Symptomatic Bacteriuria comparing Temocillin arm with Cefotaxime arm (2 arms). Primary endpoint: Ecological impact on intestinal microbiota. Started Oct 2015; status: completed.
02
Drugs
temocillincefotaxime
03
Conditions
urinary tract infection (UTI)Symptomatic Bacteriuria
Beyond the preview
Go deeper on 2015-003898-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003898-15.